Synopsis
Motivation:
Goals:
Approach:
Results:
667-03-007
ISMRM Abstract
Corrected Liver T1 (cT1) Can Be Measured Using Freely Available T1 Mapping Acquisitions
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. 1. Andersson A, Kelly M, Imajo K, et al. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clin Gastroenterol Hepatol. 2022;20(11):2451-2461.e3. doi:10.1016/j.cgh.2021.09.041 [doi]
2. 2. Jayaswal ANA, Levick C, Selvaraj EA, et al. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. Liver Int Off J Int Assoc Study Liver. 2020;40(12):3071-3082. doi:10.1111/liv.14625 [doi]
3. 3. Roca-Fernandez A, Banerjee R, Thomaides-Brears H, et al. Liver disease is a significant risk factor for cardiovascular outcomes – A UK Biobank study. J Hepatol. 2023;79(5):1085-1095. doi:10.1016/j.jhep.2023.05.046 [doi]
4. 4. Alkhouri N, Beyer C, Shumbayawonda E, et al. Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH. J Hepatol. 2025;82(3):438-445. doi:10.1016/j.jhep.2024.08.031 [doi]
5. 5. Beyer C, Andersson A, Shumbayawonda E, et al. Quantitative MRI for Monitoring Metabolic Dysfunction-Associated Steatotic Liver Disease: A Test-Retest Repeatability Study. J Magn Reson Imaging JMRI. Published online September 25, 2024. doi:10.1002/jmri.29610 [doi]
6. 6. Hernando D, Zhao R, Yuan Q, et al. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology. 2023;306(2):e213256. doi:10.1148/radiol.213256 [doi]
7. 7. Triay Bagur A, Hutton C, Irving B, Gyngell ML, Robson MD, Brady M. Magnitude-intrinsic water–fat ambiguity can be resolved with multipeak fat modeling and a multipoint search method. Magn Reson Med. 2019;82(1):460-475. doi:10.1002/mrm.27728 [doi]
8. 8. Hales P, Robson M, Fernandes C. Validation of Standardized Liver Water T1 Using MOLLI T1 Mapping Data Combined with PDFF and T2* Measurements. In: Proc. Intl. Soc. Mag. Reson. Med. 2025.
9. 9. Mozes FE, Tunnicliffe EM, Moolla A, et al. Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity. NMR Biomed. 2019;32(2):e4030. doi:10.1002/nbm.4030 [doi]
10. 10. Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed. 2011;24(7):784-790. doi:10.1002/nbm.1622 [doi]
11. 11. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16(1):2. doi:10.1186/1532-429X-16-2 [doi]
12. 12. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155-163. doi:10.1016/j.jcm.2016.02.012 [doi]
13. 13. Bachtiar V, Kelly MD, Wilman HR, et al. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PloS One. 2019;14(4):e0214921. doi:10.1371/journal.pone.0214921 [doi]
14. 14. Roca-Fernandez A, Banerjee R, Thomaides-Brears H, et al. Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study. J Hepatol. 2023;79(5):1085-1095. doi:10.1016/j.jhep.2023.05.046 [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/667-03-007